Neuralstem has received FDA approval to test the safety of injecting neural stem cells into the spinal cords of patients with amyotrophic lateral sclerosis, or Lou Gehrig's disease. Dr. Eva Feldman, a University of Michigan neurologist, will serve as the principal investigator of the clinical trial, which will be conducted at Emory University in Atlanta.

Related Summaries